KABIVEN
INF EML 4X1540ML II
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Resumption of marketing | 30.06.2021 | |||
| Interruption of marketing | 22.06.2021 |
0107104, 0107105 |
Capacity/distribution reasons | 30.06.2021 |
| Resumption of marketing | 20.04.2021 | |||
| Interruption of marketing | 05.04.2021 |
0107105 |
Capacity/distribution reasons | 30.04.2021 |
| Resumption of marketing | 01.02.2021 | |||
| Interruption of marketing | 25.01.2021 |
0107104, 0107105 |
Capacity/distribution reasons | 14.02.2021 |
| Placing on the market | 16.10.2008 |
All reports are available in the Overview.
cz